Rules-Based Medicine Gets Award to Develop Cancer Biomarker Assays

The $3 million award will go toward developing and validating multiplexed immunoassays that measure 150 to 180 blood-based biomarkers that the National Cancer Institute believes may be associated with cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.